Research Topics
| Michael B StreiffSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Thromboprophylaxis in nonsurgical patientsMichael B Streiff
Division of Hematology, Department of Medicine and Associate Faculty, Armstrong Institute of Patient Safety and Quality Care, Johns Hopkins University School of Medicine, 1830 E MonumentSt, Ste 7300, Baltimore, MD 21205, USA
Hematology Am Soc Hematol Educ Program 2012:631-7. 2012..VTE prophylaxis prescription and administration rates are suboptimal and warrant multidisciplinary performance improvement strategies...
Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literatureMichael B Streiff
Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Am J Hematol 81:684-91. 2006..The aim of this study was to evaluate the evidence on the optimal duration of vitamin K antagonist (VKA) therapy for venous thromboembolism (VTE)...- Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursementMichael B Streiff
Department of Medicine and Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
Ann Pharmacother 44:733-6. 2010..In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management... - Long-term therapy of venous thromboembolism in cancer patientsMichael B Streiff
Division of Hematology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
J Natl Compr Canc Netw 4:903-10. 2006..Several new anticoagulants are being investigated that promise greater therapeutic choices and potentially better outcomes for cancer patients with VTE... - Diagnosis and initial treatment of venous thromboembolism in patients with cancerMichael B Streiff
Johns Hopkins Anticoagulation Service and Outpatient Clinics, Special Coagulation Laboratory, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
J Clin Oncol 27:4889-94. 2009..Venous thromboembolism (VTE) is a common complication of cancer and its therapy. The purpose of this article is to review the diagnosis and initial treatment of VTE in the patient with cancer... - Anticoagulation in the management of venous thromboembolism in the cancer patientMichael B Streiff
Departments of Medicine and Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, 1830 East Monument Street, Suite 7300, Baltimore, MD 21205, USA
J Thromb Thrombolysis 31:282-94. 2011..Prospective validation of these studies and testing of current risk assessment strategies in oncology patients is warranted. Management of recurrent VTE and unsuspected VTE in the cancer patient are also reviewed... - Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposureMichael B Streiff
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
Transfusion 42:18-26. 2002..FV inhibitors are a largely preventable iatrogenic coagulopathy in which the frequency is increasing in clinical practice... - Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in traumaElliott R Haut
The Armstrong Institute for Patient Safety Division of Acute Care Surgery, Departmen of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA
Arch Surg 147:901-7. 2012.... - Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosisHyun S Kim
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Cardiovasc Intervent Radiol 29:1003-7. 2006..To compare the efficacy of catheter-directed thrombolysis (CDT) alone versus CDT with rheolytic percutaneous mechanical thrombectomy (PMT) for upper and lower extremity deep vein thrombosis (DVT)... - Management of venous thromboembolism: a systematic review for a practice guidelineJodi B Segal
Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
Ann Intern Med 146:211-22. 2007..New treatments are available for treatment of venous thromboembolism... - Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patientsHyun S Kim
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore MD 21287, USA
J Vasc Surg 47:388-94. 2008..The current study was conducted to demonstrate that catheter-directed thrombolysis for upper and lower extremity deep vein thrombosis is equally safe in patients with and without cancer... - Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costsJodi B Segal
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Am J Med 115:298-308. 2003..To summarize the evidence comparing the efficacy, safety, and costs of outpatient and inpatient treatment of venous thromboembolism... - Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomesHyun S Kim
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, MD 21287 4010, USA
J Vasc Interv Radiol 17:1099-104. 2006..To assess the clinical and economic benefits of catheter-directed thrombolysis (CDT) alone versus CDT with rheolytic percutaneous mechanical thrombectomy (PMT) for lower-extremity deep vein thrombosis (DVT)... - Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: a systematic reviewLeonardo J Tamariz
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Am J Med 117:676-84. 2004..To summarize the evidence on the predictive value of clinical prediction rules for the diagnosis of venous thromboembolism... - Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature reviewJohn Eng
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 N Wolfe St, Central Radiology Viewing Area, Rm. 117, Baltimore, MD 21287, USA
AJR Am J Roentgenol 183:1819-27. 2004..Accuracy studies of recent generations of MDCT scanners are not yet available despite the current dissemination of this technology... - Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordanceClifford M Takemoto
Department of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Am J Clin Pathol 139:450-6. 2013..In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status... - Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention CollaborativeMichael B Streiff
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
BMJ 344:e3935. 2012..Risk-appropriate prophylaxis can prevent most VTE events, but only a small fraction of patients at risk receive this treatment... - Comparative performance of two methods that assess the quality of international normalized ratio measuresKenneth M Shermock
Center for Pharmaceutical Outcomes, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Biochem 45:530-4. 2012..Both methods predict when alternate INR measures lead to different clinical decisions. Our goal was to compare their performance characteristics... - A comparison of clinical outcomes with retrievable and permanent inferior vena cava filtersHyun S Kim
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 4010, USA
J Vasc Interv Radiol 19:393-9. 2008..To compare the clinical effectiveness of retrievable and permanent inferior vena cava (IVC) filters... - Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxisDavid E Gerber
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
Cancer 109:300-5. 2007..Therefore, we conducted a retrospective review of postoperative meningioma patients receiving contemporary VTE prophylaxis and diagnostic methods to define the current incidence of and risk factors for symptomatic VTE in this population... - Vena caval filters: a review for intensive care specialistsMichael B Streiff
Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Ross Research Building, Room 1025, 720 Rutland Avenue, Baltimore, MD 21205, USA
J Intensive Care Med 18:59-79. 2003..Until additional data are available, vena caval filters should generally be restricted to patients with VTE who cannot receive anticoagulation... - Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins HospitalKimberly L Carter
The Johns Hopkins Hospital, 600 North Wolfe Street, Carnegie 180, Baltimore, MD 21287, USA
J Thromb Thrombolysis 34:437-45. 2012..Many patients fell into the "cautioned" category, which demonstrates the complexity associated with selecting candidates for these new agents... - Catheter-directed thrombolysis of inferior vena cava thrombosis in a 13-day-old neonate and review of literatureJawad U Khan
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Cardiovasc Intervent Radiol 31:S153-60. 2008..We also review the literature on CDT for treatment of IVC thrombosis in critically ill neonates and infants... - Management of venous thromboembolism in patients with primary and metastatic brain tumorsDavid E Gerber
Departments of Oncology, Medicine, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
J Clin Oncol 24:1310-8. 2006..When intracranial hemorrhage does occur, it is often due to overanticoagulation, requiring prompt anticoagulation reversal and neurosurgical consultation... - Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring programJessica C Wellman
Ambulatory Care and Anticoagulation Management, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
Am J Health Syst Pharm 68:934-9. 2011..CONCLUSION. Case-based advanced training and implementation of an IAP in a tertiary care hospital increased pharmacists' involvement in the management of inpatients receiving anticoagulants... 
Case report: perioperative use of protein c concentrate for protein C deficiency in THASavyasachi C Thakkar
Department of Orthopaedic Surgery, The Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, A665, Baltimore, MD, 21224 2780, USA
Clin Orthop Relat Res 468:1986-90. 2010..Perioperative management of patients with heterozygous protein C deficiency is challenging because of the competing risks of bleeding and recurrent thrombosis...- Venous thromboembolism in patients with HIV/AIDS: a case-control studyAima A Ahonkhai
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
J Acquir Immune Defic Syndr 48:310-4. 2008..We investigated the prevalence of established risk factors for VTE in this population and explored novel risk factors... - The role of vena caval filters in the management of venous thromboembolismChristine L Hann
Division of Hematology, Department of Medicine, Johns Hopkins Medical Institution, Bunting Blaustein Cancer Research Building, 1650 Orleans Street, Room 346, Baltimore, MD 21231, USA
Blood Rev 19:179-202. 2005..In this review, we will discuss the currently available IVC filters, data on their efficacy and safety and our assessment of appropriate indications for their use... - Results of an academic promotion and career path survey of faculty at the Johns Hopkins University School of MedicinePatricia A Thomas
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Acad Med 79:258-64. 2004..The authors sought to quantify the magnitude of this difference in career advancement and to explore the characteristics of faculty that might explain the difference... - Inflammatory bowel disease-associated thromboembolism: a systematic review of outcomes with anticoagulation versus catheter-directed thrombolysisJames H Tabibian
Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
Inflamm Bowel Dis 18:161-71. 2012..We reviewed clinical outcomes with anticoagulation (AC) and CDT in IBD patients with TE... - Heparin-induced thrombocytopenia screening and management in pediatric patientsClifford M Takemoto
Division of Pediatric Hematology, The Johns Hopkins University, Baltimore, MD 21205, USA
Hematology Am Soc Hematol Educ Program 2011:162-9. 2011..In this chapter, diagnostic approaches and management strategies based on a synthesis of the available pediatric studies and adult literature on HIT are discussed... - Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosisHyun S Kim
Division of Vascular and Interventional Radiology, Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, Maryland 21205, USA
J Vasc Interv Radiol 16:1685-91. 2005..To evaluate clinical outcomes after percutaneous treatment of superior mesenteric vein (SMV) thrombosis... - The NCCN guidelines on venous thromboembolismMichael B Streiff
Anticoagulation Management, Service and Outpatient Clinic, Staff Physician, Johns Hopkins Comprehensive Hemophilia Treatment Center, and Assistant Professor of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
Clin Adv Hematol Oncol 5:117-9. 2007 - Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapseHuichun Zhan
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Ross Research 1032, 720 Rutland Avenue, Baltimore, MD 21205, USA
Transfusion 50:868-74. 2010..We aimed to describe the clinical spectrum of TTP, to determine the valid endpoint for plasma exchange cessation, and to explore the risk factors for disease relapse... - Females with subclavian vein thrombosis may have an increased risk of hypercoagulabilityKendall Likes
Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
JAMA Surg 148:44-9. 2013..The objective of this study was to determine the prevalence of hypercoagulability in patients undergoing first rib resection and scalenectomy presenting with SVT... - Evidence-based venous thromboembolism prophylaxis is associated with a six-fold decrease in numbers of symptomatic venous thromboembolisms in rehabilitation inpatientsR Samuel Mayer
Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD 21208, USA
PM R 3:1111-1115.e1. 2011.... - Iatrogenic symptomatic chest wall hematoma after shoulder arthroplasty. A report of two casesEkavit Keyurapan
Division of Sports Medicine and Shoulder Surgery, The Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD 21224-2780, USA
J Bone Joint Surg Am 88:1603-8. 2006 - Hematological manifestations of nephropathic cystinosisAshkan Emadi
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231 1000, USA
Acta Haematol 119:169-72. 2008.... - ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomasMichael B Streiff
Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
Cancer 100:1717-23. 2004..These findings may facilitate the development of a thrombosis risk score that will allow physicians to individualize VTE prophylaxis regimens... - Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practicesElliott R Haut
Division of Acute Care Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
J Trauma 70:27-33; discussion 33-4. 2011..We hypothesized that trauma surgeons have varying opinions regarding duplex ultrasound screening for DVT in asymptomatic trauma patients, which result in varying practice patterns... - A superior method to report clinically relevant quality information about the point-of-care INR device performance compared with the International Organization for Standardization guidelinesKenneth M Shermock
Center for Pharmaceutical Outcomes, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Clin Chim Acta 411:1756-60. 2010..A revised ISO guideline was recently published that recommended methods to assess the quality of point-of-care INR measures. We assessed the relative performance of the ISO methods and a method that we developed... - The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patternsMichael B Streiff
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Blood 99:1144-9. 2002..A significant minority of physicians undertreat erythrocytosis, and little consensus exists regarding the treatment of thrombocytosis... - Venous thromboembolic disease. Clinical practice guidelines in oncologyLawrence D Wagman
City of Hope Cancer Center, USA
J Natl Compr Canc Netw 4:838-69. 2006 - The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE preventionDavid E Gerber
Division of Hematology Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA
Blood 112:504-10. 2008..2; 95% CI, 1.4-3.6). In HSCT patients, VTE is primarily catheter-related and 3-fold less common than clinically significant bleeding. These findings warrant consideration when selecting VTE prophylaxis in HSCT patients... - Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conferenceJohn A Kaufman
Dotter Interventional Institute, Oregon Health and Science University, Portland, 97239, USA
J Vasc Interv Radiol 17:449-59. 2006 - Impact of an inpatient anticoagulation management service on clinical outcomesPaula J Biscup-Horn
Anticoagulation Management Service, Department of Pharmacy, Allegheny General Hospital, Pittsburgh, PA, USA
Ann Pharmacother 42:777-82. 2008..The benefits of specialized anticoagulation management services (AMS) in the outpatient setting are well established; less evidence of benefit in the hospital setting is available... - Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismJerry A Krishnan
N Engl J Med 349:398-400; author reply 398-400. 2003 - Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conferenceJohn A Kaufman
The Dotter Interventional Institute, Oregon Health and Science University, Portland, Oregon, USA
Surg Obes Relat Dis 2:200-12. 2006